StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage applied for a PRS seven days ago

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Nov 11, 2021 11:10am

147 Views

Post# 34114976

RE:Stage applied for a PRS seven days ago

The fact that a company like StageZero is particularly interested in the early detection of the rare cancers that affect young people and is supportive of our mission is vitally important to our cause," said Simon Davies, Executive Director of Teen Cancer America. "This can help us to significantly increase awareness around adolescent and young adult cancer and the challenges that these patients face, while also working to improve the testing, detection, and treatment that could save these young lives."

--------------------
Is this why Stagezero applied for PRS 7 days ago? - Great find Nails

-------------------------

PRS

What is PRS in clinical trials?

The ClinicalTrials.gov Protocol Registration and Results System (PRS) is used to register a clinical study or submit results information for a registered study. You must have a PRS account to register study information on ClinicalTrials.gov.

How long is PRS review?

How long will the Protocol Registration and Results System (PRS) review take? After you have registered your study, the PRS review may take approximately 2 to 5 business days. The PRS review of records with results information may take up to 30 days.

Nailbiter1 wrote:

Shared with a buddy this morning.

Data providers use a Web-based data entry system called the Protocol Registration and Results System (PRS) to register clinical studies and to submit results information for registered studies. You must have a PRS account to register study information on ClinicalTrials.gov.

Staar Surgical Company

Stability Plus, LLC

Stada Arzneimittel AG

StageZero Life Sciences

Staidson (Beijing) Biopharmaceuticals Co., Ltd

Staidson Biopharma Inc.

Organizations With PRS Accounts

The organizations on this list already have Protocol Registration and Results System (PRS) accounts. Please do not create a new PRS account if your organization already has one.

https://clinicaltrials.gov/ct2/prs-orgs?fbclid=IwAR0K70MoMtxuh3H-yb72rkOqNtSyV-9_WX-Cov7IvW5Y1gu9HK9Hq1ZAWxQ#NETWORK_S